# US 2015/0177235 A1 · Lateral flow assays using dna dendrimers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0177235 A1
- Document ID: US20150177235A1
- Status: Published application
- Kind: A1
- Application number: 14/414,699
- Filed: 2013-07-12
- Published: 2015-06-25
- Earliest claimed: 2012-07-13
- Assignees: Genisphere, LLC
- Applicants: Genisphere, LLC
- Inventors: Louis J. Casta; James M. Kadushin; Lori A. Getts; Robert C. Getts
- Web page: https://patentgrep.com/patent/US20150177235A1

## CPC

- G01N 33/548: Carbohydrates, e.g. dextran
- C12Q 1/6813: Hybridisation assays
- G01N 33/54388: {based on lateral flow}
- G01N 33/76: Human chorionic gonadotropin {including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors}
- C08G 83/003: {Dendrimers}
- C12Q 2525/313: Branched oligonucleotides
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS

## Abstract

The present invention relates to lateral flow devices and kits using DNA dendrimers, and to methods for detecting an analyte using the lateral flow devices and kits. More specifically, the DNA dendrimers may be dried on a location on the test device upstream from said test zone, before said test device is used.

## Claims

### Claim 1

A test device for detecting an analyte in a liquid sample, which device comprises a porous matrix that comprises a test zone on said porous matrix, said test zone comprising a test reagent that binds to an analyte or another binding reagent that binds to said analyte, or is an analyte or an analyte analog that competes with an analyte in said sample for binding to a binding reagent for said analyte,
wherein a liquid sample flows laterally along said test device and passes said test zone to form a detectable signal to indicate presence, absence and/or amount of said analyte in said liquid sample, the formation of said detectable signal requires the use of a detectable label and a DNA dendrimer, said DNA dendrimer comprises a first component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer, and a second component that links said DNA dendrimer to said detectable label linkable to said DNA dendrimer, and wherein:
a) said analyte is not a polynucleotide; or
b) said DNA dendrimer comprises from about 1 to about 324, preferably from about 60 to about 324, from about 80 to about 300 or from about 100 to about 200, said first components; or
c) said DNA dendrimer, before said test device is used, is dried on a location on said test device upstream from said test zone.

### Claim at position 2

2-7. (canceled)

### Claim 8 (depends on 1)

A method for detecting an analyte in a liquid sample, which method comprises:
a) contacting a liquid sample with the test device of claim 1, wherein the liquid sample is applied to a site of the test device upstream of the test zone;
b) transporting an analyte, if present in the liquid sample, a detectable label and a DNA dendrimer to the test zone; and
c) assessing the presence, absence, and/or amount of a signal generated by the detectable label at the test zone to determining the presence, absence and/or amount of the analyte in the liquid sample.

### Claim at position 4

9-12. (canceled)

### Claim 13

A test device for detecting an analyte in a liquid sample, which device comprises a porous matrix that comprises a test zone on said porous matrix, said test zone comprising a test reagent that binds to an analyte or another binding reagent that binds to said analyte, or is an analyte or an analyte analog that competes with an analyte in said sample for binding to a binding reagent for said analyte,
wherein a liquid sample flows laterally along said test device and passes said test zone to form a detectable signal to indicate presence, absence and/or amount of said analyte in said liquid sample, the formation of said detectable signal requires the use of a DNA dendrimer linked to a detectable label non-covalently, and said DNA dendrimer comprises a component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer, and wherein:
a) said analyte is not a polynucleotide; or
b) said DNA dendrimer comprises from about 1 to about 324, preferably from about 60 to about 324, from about 80 to about 300 or from about 100 to about 200, said first components; or
c) said DNA dendrimer, before said test device is used, is dried on a location on said test device upstream from said test zone.

### Claim at position 6

14-21. (canceled)

### Claim 22 (depends on 13)

A method for detecting an analyte in a liquid sample, which method comprises:
a) contacting a liquid sample with the test device of claim 13, wherein the liquid sample is applied to a site of the test device upstream of the test zone;
b) transporting an analyte, if present in the liquid sample, a detectable label and a DNA dendrimer to the test zone; and
c) assessing the presence, absence, and/or amount of a signal generated by the detectable label at the test zone to determining the presence, absence and/or amount of the analyte in the liquid sample.

### Claim at position 8

23-25. (canceled)

### Claim 26 (depends on 1)

The test device of claim 1, wherein the DNA dendrimer, before the test device is used, is dried on a location on the test device upstream from the test zone, and at least about 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% of the dried DNA dendrimer is capable of being moved to the test zone by a liquid.

### Claim at position 10

27-32. (canceled)

### Claim 33 (depends on 26)

The test device of claim 26, wherein the liquid has a volume of at least about 20 ul, 25 ul, 30 ul, 35 ul, 40 ul, 45 ul, 50 ul, 55 ul, 60 ul, 65 ul, 70 ul, 75 ul, 80 ul, 85 ul, 90 ul, 95 ul, 100 ul, 110 ul, 120 ul, 150 ul, 200 ul, 300 ul, 400 ul, 500 ul, or a volume larger than 500 ul.

### Claim 34 (depends on 1)

The test device of claim 1, wherein the DNA dendrimer comprises:
a) an one-layer DNA dendrimer that comprises from about 1-2, 2-4 or 4-8 of the first and/or second component(s);
b) a two-layer DNA dendrimer that comprises from about 1-4, 4-8 or 8-18 of the first and/or second component(s);
c) a three-layer DNA dendrimer that comprises from about 2-6, 6-10, 10-18, 18-28, 28-38, 38-50 or more than 50 of the first and/or second components; and/or
d) a four-layer DNA dendrimer that comprises from about 15-25, 25-45, 45-60, 60-80, 85-105, 105-130 or more than 130 of the first and/or second components.

### Claim 35 (depends on 34)

The test device of claim 34, wherein at least one of the first component(s) and the second component(s) is a polynucleotide and the other is a non-polynucleotide moiety.

### Claim 36 (depends on 34)

The test device of claim 34, wherein the DNA dendrimer comprises:
a) an one-layer DNA dendrimer that comprises from about 1-2, 2-4 or 4-8 of the first component(s);
b) a two-layer DNA dendrimer that comprises from about 1-4, 4-8 or 8-18 of the first component(s);
c) a three-layer DNA dendrimer that comprises from about 2-6, 6-10, 10-18, 18-28, 28-38, 38-50 or more than 50 of the first components; and/or
d) a four-layer DNA dendrimer that comprises from about 15-25, 25-45, 45-60, 60-80, 85-105, 105-130 or more than 130 of the first components.

### Claim 37 (depends on 36)

The test device of claim 36, wherein the first component(s) comprise polynucleotide(s).

### Claim 38 (depends on 37)

The test device of claim 37, wherein the polynucleotide(s) are DNA strand(s).

### Claim 39 (depends on 26)

A method for detecting an analyte in a liquid sample, which method comprises:
a) contacting a liquid sample with the test device of claim 26, wherein the liquid sample is applied to a site of the test device upstream of the test zone;
b) transporting an analyte, if present in the liquid sample, a detectable label and a DNA dendrimer to the test zone; and
c) assessing the presence, absence, and/or amount of a signal generated by the detectable label at the test zone to determining the presence, absence and/or amount of the analyte in the liquid sample.

### Claim 40 (depends on 39)

The method of claim 39, wherein the signal generated by the detectable label at the test zone is enhanced by:
a) at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 folds or higher relative to a signal generated by the detectable label at the test zone using a DNA dendrimer comprising a smaller number of the first and/or second component(s); or
b) at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 150%, or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200 folds or higher relative to a signal generated by the detectable label at the test zone without using a DNA dendrimer.

### Claim 41

A test device for detecting an analyte in a liquid sample, which device comprises a porous matrix that comprises a test zone on said porous matrix, said test zone comprising a test reagent that binds to an analyte or another binding reagent that binds to said analyte, or is an analyte or an analyte analog that competes with an analyte in said sample for binding to a binding reagent for said analyte,
wherein a liquid sample is capable of flowing laterally along said test device and passing said test zone to form a detectable signal to indicate presence, absence and/or amount of said analyte in said liquid sample,
wherein:
a) the formation of said detectable signal requires the use of a detectable label and a DNA dendrimer, said DNA dendrimer comprises a first component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer, and a second component that links said DNA dendrimer to said detectable label linkable to said DNA dendrimer, or
b) the formation of said detectable signal requires the use of a DNA dendrimer linked to a detectable label covalently or non-covalently, and said DNA dendrimer comprises a third component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer,
and wherein:
c) said analyte is not a polynucleotide; and/or
d) said DNA dendrimer comprises from about 1 to about 324, preferably from about 60 to about 324, from about 80 to about 300 or from about 100 to about 200, said first components; and/or
e) said DNA dendrimer, before said test device is used, is dried on a location on said test device upstream from said test zone.

### Claim 42 (depends on 41)

A method for detecting an analyte in a liquid sample, which method comprises:
a) contacting a liquid sample with the test device of claim 41, wherein the liquid sample is applied to a site of the test device upstream of the test zone;
b) transporting an analyte, if present in the liquid sample, a detectable label and a DNA dendrimer to the test zone; and
c) assessing the presence, absence, and/or amount of a signal generated by the detectable label at the test zone to determining the presence, absence and/or amount of the analyte in the liquid sample.

### Claim 43

A kit for detecting an analyte in a liquid sample, which kit comprises:
a) a porous matrix that comprises a test zone on said porous matrix, said test zone comprising a test reagent that binds to an analyte or another binding reagent that binds to said analyte, or is an analyte or an analyte analog that competes with an analyte in said sample for binding to a binding reagent for said analyte; and
b) a DNA dendrimer, wherein:
1) said DNA dendrimer comprises a first component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer, and a second component that links said DNA dendrimer to said detectable label linkable to said DNA dendrimer, or
2) said DNA dendrimer is linked to a detectable label covalently or non-covalently and comprises a third component that links said DNA dendrimer to a binding reagent linkable to said DNA dendrimer, an analyte linkable to said DNA dendrimer, or an analyte analog linkable to said DNA dendrimer.

### Claim 44 (depends on 43)

The kit of claim 43, wherein the DNA dendrimer comprises from about 1 to about 324, preferably from about 60 to about 324, from about 80 to about 300 or from about 100 to about 200, of the first or third components.

### Claim at position 23

45-46. (canceled)

### Claim 47 (depends on 43)

The kit of any claim 43, wherein at least two of:
1) the DNA dendrimer;
2) the first binding reagent that binds to the analyte, the second binding reagent that binds to another binding reagent that binds to the analyte, the analyte or the analyte analog, each of the first binding reagent, second binding reagent, analyte or analyte analog being linkable to the DNA dendrimer; and
3) the detectable label linkable to the DNA dendrimer;
are covalently bound or crosslinked to each other.

### Claim 48 (depends on 43)

The kit of any of claim 43, wherein the DNA dendrimer comprises from about 10 to about 1,500, preferably from about 40 to about 1,500 or from about 900 to about 1,100, the detectable label.

### Claim 49 (depends on 43)

The kit of any of claim 43, wherein the DNA dendrimer comprises from about 400 to about 80,000, preferably from about 4,000 to about 80,000, or from about 60,000 to about 80,000, DNA nucleotides.

### Claim 50 (depends on 43)

The kit of any of claim 43, wherein the DNA dendrimer comprises a one-layer, a two-layer, a three-layer or a four-layer structure, or a DNA dendrimer structure comprising at least one monomeric unit as described in U.S. Pat. No. 6,274,723B1.

### Claim 51 (depends on 43)

The kit of any of claim 43, which further comprises one or more of an antibody-oligo conjugate, an analyte capture antibody, streptavidin-label, e.g., gold particle, conjugate or other label, buffers, reagents, instructions etc.
